Literature DB >> 16101160

Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.

Steffen Hauptmann1, Verena Grünewald, Denise Molls, Wolfgang D Schmitt, Martin Köbel, Karen Kriese, Annette Schürmann.   

Abstract

The high glucose consumption of tumour cells has been well known since Warburg's investigations. Nevertheless, the reason for this phenomenon is still a matter of speculation. Glucose uptake of tumour cells is mainly mediated by GLUT1. In this study, the question of whether glucose uptake as well as expression of GLUT1 are both related to tumour cell proliferation was addressed. Three kinetically different cell lines of colorectal adenocarcinomas (HRT-18, HT29 and CX-2) were used for the experiments. All the cell lines expressed GLUT1 at a high level, being mainly localized within the cell membrane and the endoplasmic reticulum. Surprisingly, the highest expression of GLUT1 was found in the most slowly proliferating cell line, CX-2. Moreover, induction of cell cycle arrest increased both GLUT1 expression and glucose consumption, as well as global protein synthesis. These data suggest that the protein synthesis of tumour cells is much more glucose-consuming than proliferation and that both processes are inversely related.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101160

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  TBK1 Facilitates GLUT1-Dependent Glucose Consumption by suppressing mTORC1 Signaling in Colorectal Cancer Progression.

Authors:  Diyuan Zhou; Yizhou Yao; Liang Zong; Guoqiang Zhou; Min Feng; Junjie Chen; Ganggang Liu; Guoliang Chen; Kang Sun; Huihui Yao; Yu Liu; Xinyu Shi; Weigang Zhang; Bo Shi; Qingliang Tai; Guanting Wu; Liang Sun; Wenqing Hu; Xinguo Zhu; Songbing He
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

2.  Evaluation of Hypoxia Inducible Factor-1α and Glucose Transporter-1 Expression in Non Melanoma Skin Cancer: An Immunohistochemical Study.

Authors:  Iman Seleit; Ola Ahmed Bakry; Dalia Rifaat Al-Sharaky; Rania Abdel Aziz Ragab; Shimaa Ahmed Al-Shiemy
Journal:  J Clin Diagn Res       Date:  2017-06-01

3.  CRISPR-Mediated Isogenic Cell-SELEX Approach for Generating Highly Specific Aptamers Against Native Membrane Proteins.

Authors:  Jonah C Rosch; Emma H Neal; Daniel A Balikov; Mohsin Rahim; Ethan S Lippmann
Journal:  Cell Mol Bioeng       Date:  2020-09-11       Impact factor: 2.321

4.  Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation.

Authors:  K Masur; C Vetter; A Hinz; N Tomas; H Henrich; B Niggemann; K S Zänker
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

Review 5.  Hyperglycemia, a neglected factor during cancer progression.

Authors:  Wanxing Duan; Xin Shen; Jianjun Lei; Qinhong Xu; Yongtian Yu; Rong Li; Erxi Wu; Qingyong Ma
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

6.  Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.

Authors:  Ghada M K GabAllah; Mona Salah El-Din Habib; Shimaa El-Shafey Soliman; Zienab A Kasemy; Suzy F Gohar
Journal:  Saudi J Gastroenterol       Date:  2017 Nov-Dec       Impact factor: 2.485

Review 7.  Alteration in Taste Perception in Cancer: Causes and Strategies of Treatment.

Authors:  Babar Murtaza; Aziz Hichami; Amira S Khan; François Ghiringhelli; Naim A Khan
Journal:  Front Physiol       Date:  2017-03-08       Impact factor: 4.566

8.  Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect.

Authors:  Thomas Sithara; K B Arun; H P Syama; T R Reshmitha; P Nisha
Journal:  Front Pharmacol       Date:  2017-09-12       Impact factor: 5.810

9.  Nutritional channels in breast cancer.

Authors:  Alejandro Godoy; Katherine Salazar; Carlos Figueroa; Gary J Smith; Maria de Los Angeles Garcia; Francisco J Nualart
Journal:  J Cell Mol Med       Date:  2008-10-13       Impact factor: 5.310

10.  miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.

Authors:  S Santasusagna; I Moreno; A Navarro; C Muñoz; F Martinez; R Hernández; J J Castellano; M Monzo
Journal:  Clin Transl Oncol       Date:  2018-01-26       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.